110 related articles for article (PubMed ID: 7060241)
1. The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.
Lupi-Herrera E; Sandoval J; Seoane M; Bialostozky D
Circulation; 1982 Apr; 65(4):645-50. PubMed ID: 7060241
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Lupi-Herrera E; Seoane M; Verdejo J; Gomez A; Sandoval J; Barrios R; Martinez W
Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
[TBL] [Abstract][Full Text] [Related]
3. Oral hydralazine therapy for primary pulmonary hypertension.
Rubin LJ; Peter RH
N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
[TBL] [Abstract][Full Text] [Related]
4. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
McGoon MD; Seward JB; Vlietstra RE; Choo MH; Moyer TP; Reeder GS
Br Heart J; 1983 Dec; 50(6):579-85. PubMed ID: 6652000
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Lupi-Herrera E; Seoane M; Verdejo J
Chest; 1984 Feb; 85(2):156-63. PubMed ID: 6692695
[TBL] [Abstract][Full Text] [Related]
7. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
Rubin LJ; Handel F; Peter RH
Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
[TBL] [Abstract][Full Text] [Related]
8. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
Tuxen DV; Powles AC; Mathur PN; Pugsley SO; Campbell EJ
Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of hydralazine on ventilation and blood gas values in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Corriveau ML; Vu-Dinh Minh ; Dolan GF
Am J Med; 1987 Nov; 83(5):886-92. PubMed ID: 3674095
[TBL] [Abstract][Full Text] [Related]
10. Significance of systemic vascular resistance in determining the hemodynamic effects of hydralazine on large ventricular septal defects.
Nakazawa M; Takao A; Chon Y; Shimizu T; Kanaya M; Momma K
Circulation; 1983 Aug; 68(2):420-4. PubMed ID: 6861317
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.
Beekman RH; Rocchini AP; Rosenthal A
Circulation; 1982 Mar; 65(3):523-8. PubMed ID: 6459891
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
Rubin LJ; Peter RH
Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
[TBL] [Abstract][Full Text] [Related]
13. Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction.
Hindman MC; Slosky DA; Peter RH; Newman GE; Jones RH; Wallace AG
Circulation; 1980 Apr; 61(4):751-8. PubMed ID: 7357717
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Corriveau ML; Shepard JW; Dolan GF
Am Rev Respir Dis; 1987 Jan; 135(1):118-22. PubMed ID: 3800141
[TBL] [Abstract][Full Text] [Related]
15. Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Piquet J; de Cremoux H; Lemaire F
Am Rev Respir Dis; 1987 Dec; 136(6):1343-9. PubMed ID: 3688636
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral hydralazine on the pulmonary hemodynamics of patients with pulmonary foreign body granulomatosis.
Farber H; Glauser FL
Chest; 1982 Dec; 82(6):708-12. PubMed ID: 7140398
[TBL] [Abstract][Full Text] [Related]
17. [10 years' experience in the use of vasodilator agents in the treatment of primary pulmonary arterial hypertension (P-PAH) (1977-1987)].
Beltrán Gámez ME; Sandoval Zarate J; Seoane M; Lupi-Herrera E
Arch Inst Cardiol Mex; 1988; 58(4):281-91. PubMed ID: 3190363
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency.
Greenberg BH; DeMots H; Murphy E; Rahimtoola S
Circulation; 1980 Jul; 62(1):49-55. PubMed ID: 7379285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
